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Abstract 
In herds with Mycoplasma bovis circulation, colostrum is often considered infectious. However, in contrast to milk, 
the presence of M. bovis in colostrum was not previously evidenced. In this survey, the presence of M. bovis DNA was 
determined with real-time PCR in 368 colostrum samples from 17 herds, recently infected with M. bovis. Only 1.9% of 
the samples tested positive, with 13 herds having no positive samples and an overall within-herd prevalence of 3.2% 
(SD: 4.9%; Range: 0–30.0%). These results show that in infected herds M. bovis DNA can be retrieved in colostrum. To 
what extend colostrum is infectious remains to be determined.
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Introduction, methods and results
Mycoplasma bovis strongly contributes to economically 
important diseases like mastitis and pneumonia and 
heavily affects animal welfare and antimicrobial use in 
modern dairy farming [1]. Prevalence seems to be ris-
ing and increasing antimicrobial resistance has been 
reported as well [2, 3].
Between animals, the major ways of M. bovis transmis-
sion are direct nose to nose contact and aerosol spread 
[1] and consumption or contact with infected milk [4]. 
Introduction into a herd generally happens through pur-
chase of replacement animals [5]. However, several other, 
currently under documented, ways of M. bovis introduc-
tion might exist. Troubling recent illustrations are the 
introduction of M. bovis in two Finnish herds by use of 
contaminated artificial insemination semen [6], and the 
first detection of M. bovis in New Zealand in July 2017 
[7, 8]. In the latter outbreak, import of embryos, feed, 
fomites, semen and other animal species were investi-
gated as sources of this introduction, since no live cattle 
were imported since 2013, but to date the source remains 
unidentified [8]. In the current mindset of reducing anti-
microbial use and improving animal health, it is imper-
ative to prevent M. bovis introduction in farms and 
countries alike.
Colostrum was mentioned as a possible source of M. 
bovis in the past [9, 10], but to the author’s knowledge, 
no studies on the prevalence of M. bovis in colostrum 
are currently available. Despite this lack of information, 
empirically designed M. bovis herd control programs 
often advocate the removal or (heat-) treatment of the 
herd’s own colostrum as a precaution measure [4]. With-
holding colostrum from neonatal calves is not an option, 
as they depend on colostrum to bridge the period from 
birth until their own immunity is fully functional [11]. 
Purchase of colostrum from other herds holds a risk for 
infectious diseases, especially paratuberculosis (Myco-
bacterium avium subsp. paratuberculosis) [12] and will 
not provide the calf with herd-specific maternal immu-
nity. Decontaminated colostrum (pasteurized or gamma 
irradiated) can be purchased, but this will result in a sig-
nificant financial burden. Heat treatment lacks, especially 
in smaller farms, economical and practical feasibility due 
to the small amounts to be processed. Furthermore, heat 
treatment destroys the cytokine and cellular fraction of 
the colostrum, which seems to affect the calves’ recovery 
after antigen exposure [13]. Knowledge on the prevalence 
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of M. bovis in colostrum is essential to guide farmers in 
the choice of which preventive or control measures are 
preferentially taken. Therefore, the main objective of this 
study was to determine the presence of M. bovis DNA 
in colostrum samples from herds with a recent M. bovis 
infection.
A survey was conducted on seventeen farms through-
out Belgium. Farms were conveniently selected by the 
local veterinarian and samples were collected through-
out 2016 and 2017. The inclusion criteria were a recent 
(less than one month) M. bovis infection in the herd, 
documented by either positive culture or PCR, and the 
willingness of the farmer to participate. Farms could 
be either beef, dairy or dairy-mixed type. Four beef, 
five dairy and eight dairy-mixed farms participated 
(Table 1). Group A farms all had positive BAL or lung 
PCR samples in calves, without information on adults, 
whereas group B farms had confirmed M. bovis infec-
tion in both adult cattle and calves. Sample size cal-
culations were preset on the available budget, which 
allowed the analysis of a total of 370 samples. Based 
on an average herd size of 80 lactating animals [3] and 
with an expected prevalence of 25% of the animals 
shedding, ten animals needed to be sampled in each 
herd to detect M. bovis with 95% confidence. A limit 
of twelve samples per herd was set on thirteen farms 
(Group A farms). Four farms with confirmed adult 
M. bovis cases were sampled for a longer time (six to 
twelve months) in an attempt to better characterize 
potential periods of shedding (Group B farms). Colos-
trum samples were collected by the farmer immediately 
post-partum after disinfection of the teats with gauze 
drenched in alcohol. A composite cow sample (pooled 
sample of all four quarters for each cow) was taken for 
each cow in a 15  mL Falcon™ tube (Fisher Scientific, 
NH, USA). Samples were stored on farm at −20 °C until 
analysis. Farmers were informed on the most ideal sam-
pling procedure and provided with the necessary mate-
rial to perform this in a repeatable fashion. Because of 
the regional availability of two different laboratories 
where samples were sent to, two different real-time 
PCR assays were used. In both laboratories, interpreta-
tion of PCR outcome was similar: samples were consid-
ered negative, borderline positive, or positive with a Ct 
value of > 40, 37–40, and < 37, respectively. As the PCR 
protocols were used for colostrum, a non-standard 
medium, both protocols were verified for this matrix 
by use of spiked colostrum samples  (108 CFU/mL). The 
samples of Group A farms were analyzed individually 
for the presence of M. bovis DNA by real-time PCR 
(VetMAX™ M. bovis kit, ThermoFisher Scientific, MA, 
USA), targeting the uvrC gene. Before analysis, samples 
were mixed with PBS, centrifuged and the supernatants 
discarded. A mix of proteinase K/ATL buffer (Qiagen, 
Hilden, Germany) was added to the pellet before cell 
lysis. DNA was automatically extracted by use of the 
MagAttract 96 cador pathogen kit (Qiagen) and King-
Fisher™ Flex 96 Deep-Well Magnetic Particle Processor 
(Thermo Fisher Scientific™), according to the manufac-
turer. In Group B farms, pooled samples were examined 
using the real-time PCR  Pathoproof® Complete 16-kit 
(Thermo Fischer Scientific™) according to the suppli-
er’s manual. Each pool consisted of five cow composite 
samples of cows belonging to the same herd. Samples of 
the M. bovis positive pools were analyzed individually 
the next day to find positive samples.
Data were entered in Excel 2016, and analyzed by 
SPSS version 25 (IBM, Armonk, New York, USA). In 
total, 368 colostrum samples from seventeen herds 
were analyzed (Table  1). M. bovis DNA was detected 
in 1.9% (7/368) of these samples, obtained from four 
different farms. Thirteen of the 17 sampled farms did 
not have any M. bovis positive colostrum samples. On 
the four farms that did have positive samples, on-farm/
within herd prevalence ranged between 2.8% (2/71) and 
30% (3/10). The average within herd prevalence was 
3.2% (standard deviation: 4.9%; range: 0–30.0%). Of the 
seven positive samples, five samples yielded a border-
line positive Ct value (> 37 and < 40). Only one farm (2 
samples) was positive in group B. No pattern of shed-
ding over time could be identified in group B farms, as 
very few samples were positive.
Table 1 Prevalence of Mycoplasma bovis in freshly calved cattle from recently infected herds.
n = number; % PCR Pos = Percentage of positive samples; p/nt = absolute number of samples positive over number of animals tested; Types: B = Beef farm; D = Dairy 
farm, M = Mixed farm.
Study group Group A Group B
Herd number 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Type B B D D M M M B M M M M M D D D B
Total n of cattle in herd 161 139 74 103 209 121 216 152 205 245 316 433 282 587 363 311 241
% PCR Pos (p/nt) 0
(0/6)
0
(0/11)
0
(0/8)
0
(0/3)
0
(0/12)
0
(0/5)
30
(3/10)
10
(1/10)
0
(0/10)
0
(0/11)
0
(0/4)
11.1
(1/9)
0
(0/11)
0
(0/63)
2.8
(2/71)
0
(0/74)
0
(0/50)
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Discussion
This study aimed at determining the prevalence of M. 
bovis in colostrum. The study faces important limita-
tions as we used the current, commercially available 
PCRs, originally manufactured for milk on colostrum 
samples. Diagnostic accuracy of these tests for colos-
trum is undocumented. We performed a limited vali-
dation to assure that positive samples are detected by 
spiking colostrum samples with M. bovis. Also, in the B 
group pooling of colostrum could have had an impact 
on the detection limit, given the high Ct value of the few 
positives detected, possibly other positive samples were 
missed. Therefore, current prevalence estimate needs to 
be interpreted carefully. Because colostrum samples can 
only be collected at one time point (just after calving), the 
decision was made to have the sampling performed by 
the farmer. Unfortunately, not all farmers complied 100% 
with the protocol and did not send in the twelve samples 
required for each farm to achieve the desired level of pre-
cision. Several PCR positive samples had a high Ct value, 
indicating only a marginal amount of M. bovis DNA pre-
sent in the sample  (Table 2). High Ct values could indi-
cate the presence of other Mycoplasma species [14], and 
very high Ct values may also indicate carryover of DNA 
between samples [15]. Even though all farmers were 
instructed to take milk samples as aseptically as possi-
ble through an on-site demonstration, it is possible the 
actual sampling was not done lege artis in every case.
Taking these limitations into account, using these 
PCRs, M. bovis DNA was only sporadically detected 
in colostrum. It is unclear whether the concentration 
of bacteria present in colostrum would suffice to infect 
calves, especially in the case of marginally positive sam-
ples. Furthermore, the presence of live bacteria was not 
verified in this study and should be investigated further.
The main finding of this study was that M. bovis DNA 
could be detected in colostrum in a small number of 
samples. In the herds where a longitudinal follow-up was 
done, only two positive samples were found on a total of 
258 samples, while M. bovis was still circulating in the 
herd during the entire study (based on sampling of clini-
cal cases on nasal swabs or milk). A variation of colostral 
shedding was seen between the tested herds in this study, 
which could indicate differences in excretion of M. bovis. 
Hypothetically, this could be based on the time of intro-
duction of M. bovis in the herd, where recently infected 
herds would have a higher level of shedding, concur-
rent with the rapid spread of a M. bovis strain through 
a seronegative population [16]. However, herd 17 was 
experiencing a large outbreak of M. bovis related disease 
in adult cattle at the time of sampling, after a primary 
introduction into the herd 1  month earlier, without any 
detectable shedding of M. bovis in the colostrum tested. 
Colostral shedding of M. bovis might also be linked to the 
disease form that M. bovis shows on a certain farm. One 
could suppose that farms suffering from M. bovis mastitis 
will have more shedding in milk. Given that case selec-
tion in group A was based on M. bovis positive tests in 
calves, this could have affected the isolation rate. How-
ever, group B farms were all selected based on M. bovis 
positive tests in adults. Overall, the within herd preva-
lence of M. bovis DNA in colostrum was very low, with 
the exception of one herd where 30% was tested positive. 
This might point to the fact that some individual herds 
are more affected, depending on the timing of infection 
of periparturient cows. Alternatively, it might be the con-
sequence of false positive PCR results due to sample con-
tamination or the presence of other Mycoplasma species 
[14, 15].
In conclusion, correct interpretation of the present 
results is crucial. M. bovis DNA is present in colostrum 
samples, albeit at low frequency. The DNA presence does 
not provide any information on the infectious risk of 
colostrum. Further work is needed to determine the risk 
of transmission trough colostrum and whether cows pos-
itive in colostrum have continued shedding in milk later 
in lactation.
Based on the findings of this study, farmers and vet-
erinarians might be motivated to apply the precaution-
ary principle and decontaminate colostrum or purchase 
colostrum (replacer). Discarding colostrum of cows suf-
fering from M. bovis related pathologies is likely a good 
advice. We also recommend practitioners and farmers 
to avoid pooling of colostrum in infected farms. Pas-
teurization [9] and purchase of colostrum (replacers) are 
options, whereas freezing and subsequent thawing only 
reduces M. bovis concentration [17]. Acid treatment [18] 
of colostrum could be investigated as an alternative. Herd 
health advisors need to be aware that the investment 
cost for on-farm pasteurization and purchase of colos-
trum (replacers) might be high and that negative effects 
on herd immunity might be the consequence. Therefore, 
Table 2 Ct-values of positive samples after real-time PCR and their interpretation.
Source herd Herd 7 Herd 8 Herd 12 Herd 15
Ct value 37.14 38.87 38.2 38.36 29.14 34.3 39.8
Interpretation Borderline Borderline Borderline Borderline Positive Positive Borderline
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these measures are potentially not in economic equilib-
rium with the transmission risk via colostrum.
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